• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SAN DIEGO, INC INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SAN DIEGO, INC INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST Back to Search Results
Model Number 99007EU
Device Problems Incorrect Or Inadequate Test Results (2456); Appropriate Term/Code Not Available (3191)
Patient Problem Coagulation Disorder (1779)
Event Date 11/27/2016
Event Type  Injury  
Manufacturer Narrative
Investigation conclusion: further investigation to determine whether the product failed to meet specifications cannot be pursued because the customer did not return the product and did not provide a lot number.The root cause cannot be determined due to insufficient information.No corrective action is required.
 
Event Description
While testing using the inratio system, the patient reportedly suffered from an eye stroke in (b)(6) 2016.The patient alleges that inaccurate inratio inr results may have caused the eye stroke event.
 
Manufacturer Narrative
Investigation conclusion: it is indicated that the product is not returning for evaluation.Therefore, a review of the entire in-house testing history of the lot was performed.The complaint lot 385941 expired prior to alere obtaining the complaint; in-house testing of the device lot was not possible.However, device lots 385940 and 385942, which originate from the same brick lot as the complaint lot, were previously tested in-house.In-house testing of these strip lots met release criteria.The product performed as expected.The manufacturing records for the lot were reviewed and the lot met release specifications.Based on the information available, there is no indication of a product deficiency and no corrective action is required.Additional information was provided in a letter received september 12, 2017.This letter included the lot number of the test strips used.The mdr has been updated to reflect the new information and the updated investigation using the lot number provided.(report type) has been updated to reflect this report is only being filed as a serious injury.The additional information received does not evidence a reportable variance or a malfunction of the device.(date of event) updated to reflect event date of as (b)(6) 2016.(date of this report) updated to reflect date of information contained in letter as 09/12/2017.(suspect medical device) have been updated to reflect new information provided.(premarket identification) updated to reflect appropriate 510k of k110212.(labeled for single use) updated to yes to reflect new information.(event problem and evaluation codes) updated to reflect findings of current investigation.
 
Event Description
Additional information was provided in a letter received september 12, 2017: the patient began using the inratio system in 2009.On (b)(6) 2016, the patient suffered a massive left eyeball effusion with a diagnosis of a subconjunctival hemorrhage.The patient then went to the hospital where he was prescribed anti-coagulants.On (b)(6) 2016, the patient tested using the inratio system and received an inr result of 5.4.The patient subsequently stopped taking the prescribed anti-coagulants.When the patient attempted to obtain additional test strips, the patient was informed of the inratio system withdrawal.The patient then decided to purchase a roche system to monitor his inr.On (b)(6) 2016, the patient received an inr result of 3.1 using the roche system.The patient's eye eventually returned to normal but the hemorrhage left a permanent cosmetic defect.Original event description: while testing using the inratio system, the patient reportedly suffered from an eye stroke in (b)(6) 2016.The patient alleges that inaccurate inratio inr results may have caused the eye stroke event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INRATIO PT/INR TEST STRIPS
Type of Device
PROTHROMBIN TIME TEST
Manufacturer (Section D)
ALERE SAN DIEGO, INC
9975 summers ridge road
san diego CA 92121
Manufacturer Contact
ya-ling king
9975 summers ridge road
san diego, CA 92121
8588052084
MDR Report Key6715683
MDR Text Key80122873
Report Number2027969-2017-00113
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodePL
PMA/PMN Number
K110212
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other
Reporter Occupation Other
Remedial Action Recall
Type of Report Initial,Followup
Report Date 09/12/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/14/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model Number99007EU
Device Lot Number385941
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received09/12/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Removal/Correction NumberZ-2354, 2362-2016
Patient Sequence Number1
Patient Outcome(s) Other;
-
-